| |
| |
|
| Insider
Information: |
Rosenbaum David P. |
| Relationship: |
Chief Development Offi... |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
376,479 |
|
|
Indirect Shares
|
236,094 |
|
|
| Direct
Value |
$2,300,287 |
|
|
|
Indirect Value
|
$1,442,534 |
|
|
| Total
Shares |
612,573 |
|
|
| Total
Value |
$3,742,821 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
36
|
|
Stock
price went up :
|
1
|
23
|
| Stock
price went down : |
0
|
13
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.8
|
| Percentage
Gain/Loss : |
 276.6%
|
2,864.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardelyx Inc |
ARDX |
Chief Development Offi... |
2024-06-03 |
376,479 |
2024-06-03 |
236,094 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
79 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2017-03-10 |
4 |
S |
$13.48 |
$13,482 |
I/I |
(1,000) |
1,277 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-11-30 |
4 |
AS |
$4.50 |
$13,500 |
D/D |
(3,000) |
359,543 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2018-11-13 |
4 |
S |
$2.84 |
$15,819 |
D/D |
(5,570) |
165,612 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2024-05-21 |
4 |
S |
$7.81 |
$17,169 |
I/I |
(2,198) |
176,374 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-21 |
4 |
AS |
$22.09 |
$17,674 |
I/I |
(800) |
74,252 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-21 |
4/A |
AS |
$22.09 |
$17,674 |
D/D |
(800) |
22,540 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2020-09-15 |
4 |
S |
$5.51 |
$19,131 |
I/I |
(3,470) |
21,662 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• • – |
2024-02-20 |
4 |
S |
$8.75 |
$20,064 |
I/I |
(2,294) |
181,119 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-05-28 |
4 |
S |
$7.22 |
$22,098 |
I/I |
(3,062) |
26,750 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-01 |
4 |
AS |
$18.32 |
$23,560 |
I/I |
(1,286) |
0 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-03 |
4 |
AS |
$19.25 |
$24,082 |
D/D |
(1,251) |
25,880 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2017-04-18 |
4 |
S |
$11.98 |
$24,577 |
D/D |
(2,051) |
40,129 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-06-06 |
4 |
S |
$0.64 |
$28,628 |
D/D |
(44,004) |
303,916 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-12-18 |
4 |
AS |
$6.07 |
$34,447 |
D/D |
(5,675) |
316,596 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2024-05-21 |
4 |
S |
$7.81 |
$37,922 |
D/D |
(4,855) |
376,479 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-07-30 |
4 |
AS |
$19.27 |
$38,755 |
I/I |
(2,011) |
75,581 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-07-30 |
4/A |
AS |
$19.27 |
$38,755 |
D/D |
(2,011) |
25,880 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-12-14 |
4 |
AS |
$5.55 |
$38,850 |
D/D |
(7,000) |
322,271 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-04-06 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
160,047 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• • – |
2024-02-20 |
4 |
S |
$8.75 |
$43,880 |
D/D |
(5,017) |
378,985 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• • – |
2024-02-26 |
4 |
S |
$9.20 |
$47,684 |
I/I |
(5,183) |
175,936 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-12-05 |
4 |
AS |
$5.00 |
$51,360 |
D/D |
(10,272) |
349,271 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-15 |
4/A |
AS |
$22.01 |
$55,898 |
D/D |
(2,540) |
23,340 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-15 |
4 |
AS |
$22.01 |
$55,898 |
I/I |
(2,540) |
75,052 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-12-08 |
4 |
AS |
$5.27 |
$105,476 |
D/D |
(20,000) |
329,271 |
0 |
% |
|
79 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
